NCT02985957 2025-12-22
CheckMate 650
Bristol-Myers Squibb
Phase 2 Completed
Clinical Trials
7 trialsNCT05005728 2025-07-17
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc.
Phase 2 Completed
NCT06890832 2025-03-24
A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer
Jina Pharmaceuticals Inc.
Phase 2 Not yet recruiting
NCT04495179 2023-08-09
AARDVARC
AstraZeneca
Phase 2 Completed
NCT02379390 2019-06-21
PRIMCAB
Sanofi
Phase 2 Terminated
NCT01718353 2017-11-20
TAXYNERGY
Sanofi
Phase 2 Completed
NCT01576029 2013-12-24
SWITCH
Sanofi
Phase 2 Completed